Tom van Wezel

10.7k total citations
188 papers, 5.7k citations indexed

About

Tom van Wezel is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology. According to data from OpenAlex, Tom van Wezel has authored 188 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pathology and Forensic Medicine, 76 papers in Cancer Research and 75 papers in Oncology. Recurrent topics in Tom van Wezel's work include Genetic factors in colorectal cancer (88 papers), Cancer Genomics and Diagnostics (61 papers) and Colorectal Cancer Treatments and Studies (23 papers). Tom van Wezel is often cited by papers focused on Genetic factors in colorectal cancer (88 papers), Cancer Genomics and Diagnostics (61 papers) and Colorectal Cancer Treatments and Studies (23 papers). Tom van Wezel collaborates with scholars based in Netherlands, United States and United Kingdom. Tom van Wezel's co-authors include Hans Morreau, Ronald van Eijk, Dina Ruano, Jan Oosting, Noel F.C.C. de Miranda, Frederik J. Hes, Marjo van Puijenbroek, Vincent T.H.B.M. Smit, Willem E. Corver and Gert Jan Fleuren and has published in prestigious journals such as Science, Nature Communications and Nature Genetics.

In The Last Decade

Tom van Wezel

182 papers receiving 5.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom van Wezel Netherlands 42 2.4k 2.1k 1.9k 1.7k 910 188 5.7k
Ralf Bützow Finland 53 3.0k 1.3× 1.8k 0.9× 1.6k 0.9× 1.3k 0.7× 1.1k 1.3× 188 7.4k
Manuel R. Teixeira Portugal 43 3.4k 1.4× 1.7k 0.8× 1.9k 1.0× 1.3k 0.8× 1.3k 1.4× 225 6.4k
Aaron Pollett Canada 33 2.6k 1.1× 3.9k 1.8× 1.7k 0.9× 1.3k 0.7× 512 0.6× 87 6.8k
Michael Datto United States 34 4.1k 1.7× 2.2k 1.0× 1.4k 0.8× 875 0.5× 802 0.9× 69 6.4k
Colin C. Pritchard United States 34 3.0k 1.3× 2.2k 1.0× 3.2k 1.7× 1.7k 1.0× 598 0.7× 133 6.6k
Ruth Holm Norway 45 2.8k 1.2× 2.8k 1.3× 1.3k 0.7× 991 0.6× 403 0.4× 187 6.1k
Rosemary R. Millis United Kingdom 44 1.7k 0.7× 2.5k 1.1× 2.2k 1.2× 1.9k 1.1× 882 1.0× 117 5.9k
Maria Flavia Di Renzo Italy 40 4.0k 1.7× 1.9k 0.9× 995 0.5× 744 0.4× 495 0.5× 106 7.4k
Frederic M. Waldman United States 53 3.9k 1.6× 2.5k 1.2× 2.9k 1.5× 1.6k 0.9× 2.0k 2.2× 136 8.0k
Kokichi Sugano Japan 35 1.5k 0.6× 1.3k 0.6× 896 0.5× 1.1k 0.6× 485 0.5× 148 3.6k

Countries citing papers authored by Tom van Wezel

Since Specialization
Citations

This map shows the geographic impact of Tom van Wezel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom van Wezel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom van Wezel more than expected).

Fields of papers citing papers by Tom van Wezel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom van Wezel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom van Wezel. The network helps show where Tom van Wezel may publish in the future.

Co-authorship network of co-authors of Tom van Wezel

This figure shows the co-authorship network connecting the top 25 collaborators of Tom van Wezel. A scholar is included among the top collaborators of Tom van Wezel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom van Wezel. Tom van Wezel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steeghs, Elisabeth M. P., C. J. Timmer, Jasper N. Smit, et al.. (2025). Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC. Lung Cancer. 209. 108771–108771.
2.
Terradas, Mariona, Pilar Mur, Chiara Maria Lavinia Löffler, et al.. (2025). Constitutional epimutations in LTBP4, a component of the TGF-β signaling, and in BRCA1, as potential drivers of early-onset colorectal cancer. Clinical Epigenetics. 17(1). 183–183. 1 indexed citations
3.
Brandsma, Dieta, Els Verhoeven, Kim Monkhorst, et al.. (2025). Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluid. European Journal of Cancer. 229. 115783–115783. 1 indexed citations
4.
Boot, Arnoud, Quinten R. Ducarmon, Sam Nooij, et al.. (2024). Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients. BMC Cancer. 24(1). 104–104. 5 indexed citations
5.
Ruano, Dina, Sebastien M. Joruiz, Mar Rodríguez‐Girondo, et al.. (2024). Germline variant affecting p53β isoforms predisposes to familial cancer. Nature Communications. 15(1). 8208–8208. 1 indexed citations
6.
Harryvan, Tom J., Lukas J.A.C. Hawinkels, Akin Inderson, et al.. (2022). A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation. SHILAP Revista de lepidopterología. 1(4). 678–681. 13 indexed citations
7.
Carvalho, Beatriz, Tom van Wezel, Gerrit A. Meijer, et al.. (2022). Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors. British Journal of Cancer. 127(11). 1991–1996. 2 indexed citations
8.
Boonen, Rick A.C.M., Wouter W. Wiegant, Bas Vroling, et al.. (2021). Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk. Cancer Research. 82(4). 615–631. 33 indexed citations
9.
Woei-A-Jin, Feng Jung Sherida H., Nir I. Weijl, Mark C. Burgmans, et al.. (2021). Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study. The Oncologist. 26(10). 854–864. 20 indexed citations
10.
Kemps, Paul G., Arjen H.G. Cleven, Tom van Wezel, et al.. (2020). B‐cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement. American Journal of Hematology. 95(11). 1427–1429. 3 indexed citations
11.
Nooij, Linda S., Natalja T. ter Haar, Dina Ruano, et al.. (2017). Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance. Clinical Cancer Research. 23(22). 6781–6789. 117 indexed citations
12.
Mulder, Babs G. Sibinga, J. Sven D. Mieog, Arantza Fariña Sarasqueta, et al.. (2017). Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer. Journal of Clinical Pathology. 71(3). 246–252. 9 indexed citations
13.
Drost, Jarno, Ruben van Boxtel, Francis Blokzijl, et al.. (2017). Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer. Science. 358(6360). 234–238. 312 indexed citations
14.
Zhang, Yixiang, Jolieke G. van Oosterwijk, Ewa Sicińska, et al.. (2013). Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy. Clinical Cancer Research. 19(14). 3796–3807. 75 indexed citations
15.
Bastiaannet, Esther, Ronald van Eijk, Ronald L. P. van Vlierberghe, et al.. (2013). COX-2 expression influences the prognostic effect of aspirin use after diagnosis in colon cancer patients. European Journal of Cancer. 49.
16.
Miranda, Noel F.C.C. de, Ekaterina S. Jordanova, Carli M.J. Tops, et al.. (2012). Infiltration of Lynch Colorectal Cancers by Activated Immune Cells Associates with Early Staging of the Primary Tumor and Absence of Lymph Node Metastases. Clinical Cancer Research. 18(5). 1237–1245. 28 indexed citations
17.
Middeldorp, Anneke, Shantie Jagmohan–Changur, Ronald van Eijk, et al.. (2009). Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort. Cancer Epidemiology Biomarkers & Prevention. 18(11). 3062–3067. 53 indexed citations
18.
Schrage, Yvonne, Inge H. Briaire‐de Bruijn, Noel F.C.C. de Miranda, et al.. (2009). Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment. Cancer Research. 69(15). 6216–6222. 84 indexed citations
19.
Lips, Esther H., Ronald van Eijk, Eelco J. R. de Graaf, et al.. (2008). Progression and Tumor Heterogeneity Analysis in Early Rectal Cancer. Clinical Cancer Research. 14(3). 772–781. 35 indexed citations
20.
Corver, Willem E., Anneke Middeldorp, Natalja T. ter Haar, et al.. (2008). Genome-wide Allelic State Analysis on Flow-Sorted Tumor Fractions Provides an Accurate Measure of Chromosomal Aberrations. Cancer Research. 68(24). 10333–10340. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralf Bützow Breakdown of academic impact, for papers by Manuel R. Teixeira Breakdown of academic impact, for papers by Aaron Pollett Breakdown of academic impact, for papers by Michael Datto Breakdown of academic impact, for papers by Colin C. Pritchard Breakdown of academic impact, for papers by Ruth Holm Breakdown of academic impact, for papers by Rosemary R. Millis Breakdown of academic impact, for papers by Maria Flavia Di Renzo Breakdown of academic impact, for papers by Frederic M. Waldman Breakdown of academic impact, for papers by Kokichi Sugano
Rankless by CCL
2026